(NASDAQ: LSTA) Lisata Therapeutics's forecast annual revenue growth rate of 241.23% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Lisata Therapeutics's revenue in 2025 is $1,000,000.On average, 1 Wall Street analysts forecast LSTA's revenue for 2025 to be $8,598,204, with the lowest LSTA revenue forecast at $8,598,204, and the highest LSTA revenue forecast at $8,598,204. On average, 1 Wall Street analysts forecast LSTA's revenue for 2028 to be $61,907,069, with the lowest LSTA revenue forecast at $61,907,069, and the highest LSTA revenue forecast at $61,907,069.
In 2029, LSTA is forecast to generate $386,919,180 in revenue, with the lowest revenue forecast at $386,919,180 and the highest revenue forecast at $386,919,180.